JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY is a distinguished peer-reviewed journal published by Pergamon-Elsevier Science Ltd, committed to advancing the fields of biochemistry, molecular biology, and endocrinology. With an ISSN of 0960-0760 and an E-ISSN of 1879-1220, this journal has garnered a notable reputation, securing a Q2 ranking in numerous categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, as of 2023. Hailing from the United Kingdom, it serves as a critical platform for the dissemination of impactful research from 1990 to 2025 and beyond. Although it does not currently offer open access options, the journal's comprehensive coverage and rigorous peer review process ensure high-quality publications that significantly contribute to the understanding of steroid biochemistry and related fields. Targeting a diverse audience of researchers, professionals, and students, the journal remains an essential resource for those seeking to stay at the forefront of scientific innovation and discovery.

Sexual Medicine, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of sexual health and medicine since its inception in 2013. With an E-ISSN of 2050-1161, this journal provides a platform for high-quality research that spans multiple disciplines including Behavioral Neuroscience, Dermatology, Endocrinology, Psychiatry and Mental Health, and Reproductive Medicine. Notably, the journal has maintained a solid standing in its category quartiles, with rankings reflecting its significant impact in the fields of Urology (Rank #18/120, 85th Percentile) and Reproductive Medicine (Rank #25/90, 72nd Percentile), among others. The open-access model enhances accessibility to groundbreaking research, ensuring that knowledge is disseminated widely to researchers, healthcare professionals, and students alike. With a commitment to fostering a deeper understanding of the complexities surrounding sexual health, Sexual Medicine endeavors to provide critical insights and foster discussions that drive innovation and improvement in clinical practices. Discover more and stay updated on the latest findings in sexual health by engaging with this invaluable resource on a global scale.

PROSTATE is a premier, peer-reviewed journal published by Wiley, focusing on the critical fields of urology and oncology. With an established history since 1980 and a projected convergence through 2024, this influential journal serves as a vital resource for researchers, clinicians, and students alike. It holds a prestigious position in the academic landscape, classified in the Q1 category for Urology and Q2 in Oncology as of 2023, demonstrating its significant contribution to these disciplines. With a Scopus rank of #23 in Urology and #169 in Oncology, PROSTATE is pivotal for advancing knowledge and fostering innovation in prostate research, treatment, and overall male health. The journal aims to publish high-quality original articles, reviews, and clinical studies that address the complexities of prostate-related conditions, ultimately seeking to improve patient outcomes and propagate best practices in the medical community.

Nature Reviews Urology, published by NATURE PORTFOLIO, stands as a leading journal in the field of urology, showcasing cutting-edge research and reviews that address the complexities and advancements within this dynamic medical specialty. With a 2023 impact factor that places it firmly in the Q1 quartile of urology journals, it ranks impressively within the top 3 out of 120 in Scopus, highlighting its critical role in disseminating significant academic findings. As a premier source of scholarly information, this journal aims to provide urology professionals, researchers, and students with comprehensive insights into the latest clinical practices, therapeutic developments, and technological innovations, promoting a deeper understanding of urological conditions. The journal also ensures accessibility to its articles, demonstrating a commitment to the open dissemination of knowledge essential for advancing urology research and practice.

Andrology, an esteemed journal published by WILEY, is dedicated to advancing the field of reproductive health and medicine. With an ISSN of 2047-2919, this journal spans critical topics in andrology, urology, and endocrinology, reflecting its strong commitment to scholarly excellence and innovation. As a Q1 ranked journal in both Reproductive Medicine and Urology, Andrology boasts impressive Scopus rankings, standing at 6th in Reproductive Medicine and 8th in Urology, placing it in the top 10% of its field. The journal is accessible as an Open Access platform, ensuring that valuable research findings are available to a broader audience. With significant impact evidenced by its categorization in Q2 for Endocrinology and Diabetes and Metabolism, Andrology serves as an essential resource for researchers, clinicians, and students alike, supporting the continued advancement of knowledge and practice in male reproductive health.

Clinical and Experimental Reproductive Medicine (CERM) is a premier journal dedicated to advancing the field of reproductive medicine. Published by the Korean Society of Reproductive Medicine, it aims to disseminate high-quality research and innovative clinical practices in reproductive health and medicine. With its Q3 ranking in reproductive medicine for 2023, CERM is positioned as a significant resource for researchers and practitioners seeking to stay current with the latest developments and findings in the field. Since its inception in 2011, CERM has provided a vital platform for original research articles, review papers, and case studies that cover a range of topics, including fertility treatments, reproductive endocrinology, and embryology. Researchers benefit from its accessibility, inspiring new insights and evidence-based approaches to clinical practices. Based in South Korea, its rigorous peer-reviewed publication process ensures that all contributions meet high academic standards, making it an invaluable asset for anyone engaged in reproductive health research or practice.

BMC Urology is a premier open-access journal dedicated to advancing research in the field of urology, reproductive medicine, and miscellaneous aspects of medicine. Published by BMC since 2001 and based in the United Kingdom, this journal provides a platform for researchers, clinicians, and students to disseminate their findings and explore the latest innovations and advancements within these vital fields. With a notable impact factor and categorization in the Q2 quartile for various categories of medicine, BMC Urology stands as a reputable source, ranking 51st out of 120 in Urology and 44th out of 90 in Reproductive Medicine according to Scopus metrics. The journal fosters knowledge sharing through its open-access model, ensuring that research is accessible to all. As it converges from 2001 to 2024, BMC Urology continues to play a crucial role in shaping the landscape of urological research and providing invaluable insights into clinical practices.

Prostate International is a leading open-access journal published by Elsevier Inc, dedicated to advancing research and knowledge in the field of urology, particularly focusing on prostate health and disease. Since its inception in 2013, the journal has preserved its commitment to disseminating high-quality, peer-reviewed articles that contribute significantly to clinical practices and scientific understanding. With an impressive Q1 ranking in urology and a current position as rank #35/120 among urology journals in Scopus, it occupies a prominent place in the academic landscape, ensuring that cutting-edge research reaches a broad audience. The journal's open-access policy enhances visibility and accessibility, fostering collaboration among researchers, healthcare professionals, and students. With the range of topics covered, from innovative treatments to diagnostic advancements, Prostate International serves as a vital resource for those committed to improving patient outcomes and driving the future of urological health.

Revista Internacional de Andrologia, published by Elsevier España SLU, is a pivotal academic journal advancing the field of andrology, particularly focusing on reproductive medicine and urology. With an ISSN of 1698-031X and recognized as a reputable source within the medical community, this journal holds a Q3 ranking in both Reproductive Medicine and Urology as of 2023, reflecting its significant contribution to the field. Researchers and professionals are encouraged to engage with a diverse range of articles published annually, offering insights into current trends, innovative methodologies, and emerging challenges. Although the journal is not open access, it is an essential resource for those seeking to stay at the forefront of research and practice in andrology, making it a valuable tool for academics and clinicians alike. As the journal progresses through its converged years from 2005 to 2024, it remains committed to fostering collaboration and knowledge dissemination within the global medical community.

PROSTATE CANCER AND PROSTATIC DISEASES, published by SpringerNature, is a prestigious international journal dedicated to advancing knowledge in the fields of cancer research, oncology, and urology, as evidenced by its Q1 rankings in 2023. Established in 1997, this journal has become a vital resource for researchers, clinicians, and healthcare professionals, offering impactful research and clinical insights on prostate health and disease. With its focus on innovative studies and comprehensive reviews, it addresses critical challenges in the management and treatment of prostate cancer, driving improvements in patient care globally. The journal's standing is further supported by its impressive Scopus rankings, placing it in the top tier of its categories. Readers can access high-quality, peer-reviewed articles that contribute significantly to ongoing medical practices and improve therapeutic strategies for prostate-related health issues.